Tissue specific Cish expression supports alveolar macrophage homeostatic function by Shoger, Karsen E.
   
Title Page 
Tissue Specific Cish Expression Supports Alveolar Macrophage Homeostatic Function 
 
 
 
 
 
 
 
 
by 
 
Karsen E. Shoger 
 
BS, Biological Sciences, University of Pittsburgh, 2017 
 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of the 
 
Department of Infectious Diseases and Microbiology 
 
Graduate School of Public Health in partial fulfillment 
  
of the requirements for the degree of 
 
Master of Science 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
 
2019
 ii 
Committee Page 
UNIVERSITY OF PITTSBURGH 
 
GRADUATE SCHOOL OF PUBLIC HEALTH 
 
 
 
 
 
 
 
 
 
This thesis was presented 
 
by 
 
 
Karsen E. Shoger 
 
 
It was defended on 
 
December 3, 2019 
 
and approved by 
 
Thesis Advisor: Rachel Gottschalk, PhD, Assistant Professor, Department of Immunology 
School of Medicine, University of Pittsburgh 
 
Robbie Mailliard, PhD, Assistant Professor, Infectious Diseases and Microbiology  
Graduate School of Public Health, University of Pittsburgh 
 
Joshua Mattila, PhD, Assistant Professor, Infectious Diseases and Microbiology 
Graduate School of Public Health, University of Pittsburgh  
 
  
 iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © by Karsen E. Shoger 
 
2019 
 
 
 
 
 iv 
Abstract 
Rachel Gottschalk, PhD 
 
Tissue Specific Cish Expression Supports Alveolar Macrophage Homeostatic Function 
 
Karsen E. Shoger, MS 
 
University of Pittsburgh, 2019 
 
 
Abstract 
 
Macrophages play critical roles in defense against microbes and clearance of dead cells, 
but also perform tissue specific functions in homeostasis. Distinct gene expression signatures in 
macrophages isolated from varying tissues are largely determined by environmental signals. 
Specifically, the lung is highly susceptible to environmental changes, such as O2 pressure and 
inhalation of particulate and microbes. Alveolar macrophages are shaped by the lung environment 
and have critical tissue-specific functions in initiating and resolving lung inflammation, and in 
maintaining lung structure via surfactant and lipid catabolism. While research speculates lung 
specific factors form alveolar macrophage phenotype and homeostatic function, the specific 
signals and regulators remain largely unknown. Therefore, we sought to explore lung specific 
cytokine signals and downstream signaling regulators that shape homeostatic functions of alveolar 
macrophages. 
We found Cytokine Inducible SH2 Containing Protein (Cish), a SOCS family member 
known to regulate the JAK-STAT5 pathway, is basally expressed in a tissue-specific manner in 
alveolar macrophages. Further, we found that the STAT5 activating cytokine GM-CSF regulates 
Cish expression in alveolar macrophages and observed reduced alveolar macrophage Cish 
expression with GM-CSF blockade in the lung. Cish knockout mice exhibit enlarged “foamy” 
alveolar macrophages, impaired surfactant metabolism, and dysregulated response to GM-CSF, 
all hallmarks of pulmonary alveolar proteinosis. Thus, we show alveolar macrophage Cish 
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expression is directly linked to lung specific factors, namely GM-CSF, and influences surfactant 
homeostasis in the lung, a critical homeostatic function of alveolar macrophages.  
The lung is an especially critical site of protection as it is a barrier site that is constantly 
exposed to inhaled particulate and microbes and possesses a fragile structure. Alveolar 
macrophages act as sentinels in the lung, protecting this sensitive tissue from challenge while 
maintaining proper homeostasis and structure. From a public health perspective, continuing to 
elucidate the specific mechanisms by which alveolar macrophages mediate lung homeostasis is 
essential to providing cutting edge health care and to continuing to develop therapeutic treatments 
that can provide cures instead of simply mitigating symptoms of pulmonary disease. Here, we 
highlight one of many yet to be uncovered regulators of lung homeostasis.  
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1.0 Introduction 
1.1 Macrophages in Health and Disease 
1.1.1 Macrophages in innate immunity 
Macrophages play critical roles as phagocytes in defense against microbes and clearance 
of dead cells. Elie Mechnikoff characterized macrophages in the early 1900s based on their unique 
phagocytic capabilities and proposed that macrophages actively surveilled and phagocytosed 
foreign material to protect their host1. Thus, the discovery of macrophages set the stage for innate 
immunology and early research focused heavily on the immune functions of macrophages. 
Macrophages are an essential part of the innate immune system. Constantly surveilling 
tissue, macrophages are one of the first immune cells to see and respond to antigens via expression 
of a wide variety of innate immune receptors (Figure 1), which can recognize both endogenous 
and exogenous danger signals. These danger signals are detected through pattern recognition 
receptors (PRRs), such as Toll-like receptors (TLRs), complement receptors, and other scavenger 
receptors. Upon ligation of these receptors, macrophages become activated and initiate a pro-
inflammatory response, typically through release of pro-inflammatory factors such as TNF, iNOS, 
IL-12, and various chemokines. This initial pro-inflammatory phenotype, typically described as 
“classically activated” or M1, results in recruitment of other effector immune cells and ultimately 
generates an adaptive immune response. These soluble factors also increase vascular permeability 
and enhance antimicrobial activity of macrophages and other effector cells. 
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Figure 1. The diverse array of innate immune receptors expressed by macrophages. 
Macrophages express a wide variety of receptors, many of which are PRRs, for sensing of microbial 
products or dead cells. Figure reproduced from BMC Biology2. 
 
While pro-inflammatory responses are critical for host defense, they can also result in 
tissue damage. After initial inflammation, macrophages adopt a tissue repair phenotype, typically 
described as M2. Classical wound healing macrophages are associated with responses to IL-4. 
Upon sensing IL-4, macrophages begin to upregulate anti-inflammatory factors as well as factors 
that promote tissue repair, such as arginase, which contributes to production of extracellular 
matrix. 
While the binary M1/M2 classification is prevalent in the literature, it fails to account for 
the diverse plasticity of macrophages. For example, macrophages can take on regulatory function 
without contributing to tissue repair. Such regulatory macrophages produce high levels of IL-10, 
but lack IL-12 and arginase secretion and do not express CD80, CD86, and MHCII, so therefore 
do not fit neatly into the predominant M1/M2 paradigm. Thus, the field is moving towards 
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conceptualizing macrophage function as a spectrum between classically activated macrophages, 
wound-healing macrophages, and regulatory macrophages3. 
1.1.2 Tissue resident macrophages in health and disease 
Macrophages’ phenotypes are highly context dependent, with macrophages adopting 
functional states based on environmental signals. In addition to direct immune functions, 
macrophages are increasingly being recognized for their essential roles in tissue structure and 
homeostasis. In many tissues, macrophages do not only phagocytose foreign material, but also 
endogenous material4. As phagocytes, macrophages play a critical role in clearance of apoptotic 
cells and cellular debris from tissues. This tissue homeostasis is quiescent, either independent of 
immune receptors or regulated by inhibitory signals.   
In addition to phagocytosis, tissue resident macrophages often perform synergistic 
functions specific to their tissue of residence. For example, in adipose tissue, macrophages regulate 
insulin sensitivity and adaptive thermogenesis5. Bone marrow macrophages support erythropoiesis 
and maintain hematopoietic stem cells in stem cell niches, while microglia play an essential role 
in neuronal remodeling by promoting neuronal survival and removing dead neurons6, 7, 8. 
Dysregulation of homeostasis highlights the important role of macrophages in maintaining tissue 
health and integrity and macrophages are implicated as key players in a number of inflammatory 
and autoimmune diseases. In the case of multiple sclerosis, dysregulation of communication 
between astrocytes and microglia is a driver of axon demyelination and resultant disease9. 
Macrophage hyperresponsiveness to gut microbiota drives the chronic inflammation that leads to 
Crohn’s disease and inflammatory bowel disease10, 11. Inflammatory cytokine secretion by 
macrophages is often a major driver of disease progression, as evidenced in the case of macrophage 
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produced cytokines in the synovial fluid around joints that promotes rheumatoid arthritis12. These 
inflammatory diseases point to the importance of macrophages in tissue homeostasis, with specific 
emphasis on proper cross talk between macrophages and their tissue of residence.  
Macrophages are extremely plastic and adapt their function and phenotype based on 
presence or absence of specific stimuli. The combination of input signals from these stimuli shape 
macrophages into an diverse range of phenotypes and drive a multitude of functions, resulting in 
heterogeneity across tissue resident macrophages, with well described differences in gene 
expression and protein expression signatures across tissue resident subsets2, 13, 14, 15, 16.  The best 
described tissue specific transcription factor signatures include Gata6 expression in peritoneal 
macrophages17, 18, Smad3 expression in microglia19, Lxra expression in Kupffer cells20 and splenic 
macrophages21, and Pparg expression in alveolar macrophages22, 23.  
While tissue derived factors are thought to drive these distinct tissue resident macrophage 
signatures, only a few tissue specific factors have been well described as driving tissue specific 
signatures in macrophages. Retinoic acid present in the peritoneal omentum drives Gata6 
expression in peritoneal macrophages, which is essential for localization of peritoneal 
macrophages as well peritoneal macrophage regulation of gut IgA responses17. GM-CSF in the 
lung drives Pparg expression, which is critical for perinatal development of alveolar macrophages. 
GM-CSF deficiency results in “foamy” alveolar macrophages, which are unable to properly 
maintain surfactant homeostasis in the lung23. Splenic macrophages rely on oxysterol in the spleen, 
which drives expression of Lxra21. Lxra deficient splenic macrophages fail to fully mature, 
resulting in improper spleen structure and impaired pathogen clearance20. The strong TGF-β signal 
in the brain drives Smad3 expression essential for proper microglia phenotype and function24. Loss 
of TGF-β signal results in a hyperinflammatory microglia phenotype which causes unnecessary 
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tissue damage in the brain25, 26. While these examples strongly support the notion of tissue specific 
factors driving unique tissue resident macrophage signatures, they only account for a few of the 
many tissue specific factors that potentially impact tissue resident macrophage signatures. 
1.2 Alveolar Macrophages and Lung Homeostasis 
1.2.1 Alveolar macrophages immune function 
The lungs are a barrier site not only with a large surface area and fragile structure, but also 
undergo constant environmental changes, such as fluctuations in gas exchange, hypoxia, changes 
in the lung microflora, and inhalation of particulate and other substances27. Further, damage to the 
lungs leads to improper gas exchange, easy access of microbes to the bloodstream, or potential 
edema. Alveolar macrophages are one of the most abundant immune cells to occupy this unique 
tissue and must tolerate and adapt to these constant environmental changes, while conferring heavy 
protection with minimal tissue damage28. 
In homeostasis, alveolar macrophages clear dead cells, particulate, and microbes with 
minimal initiation of pro-inflammatory responses in order to prevent unnecessary damage to the 
alveolar epithelium. The lung environment is known to dampen alveolar macrophage pro-
inflammatory responses through both cell-to-cell contact and soluble factors. Alveolar 
macrophages remain closely adhered to alveolar epithelial cells (AECs) through surface receptors 
and form gap junction channels with AECs, which transduce Ca2+ signals and allow direct 
communication between the alveolar epithelium and alveolar macrophages to modulate immune 
responses29. Alveolar macrophages also communicate with AECs through a number of surface 
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receptors such as CD200R, MARCO, TREM2, TGF-βR, and SIRPa, which serve 
immunomodulatory roles in order to prevent unwarranted airway inflammation27.  
Alveolar macrophages also directly contribute to the immunosuppressive environment in 
the steady state lung. Alveolar macrophages have been reported to secrete SOCS1 and SOCS3 in 
exosomes to suppress inflammation in other cells in the lung30. Close contact of alveolar 
macrophages with AECs induces activation of TGF-β, a major regulator of immune function in 
the steady state lung31. This localized TGF-β signal is one of many immunomodulatory factors 
present in the lung that allow alveolar macrophages to silently surveil the lung. Alveolar 
macrophages also actively suppress adaptive immune responses, regulating both alveolar dendritic 
cell function and T cell activation32. Depletion of alveolar macrophages leads to inflammatory 
reactions to otherwise harmless challenges, demonstrating their critical role in lung homeostasis33.  
Upon invasive infection, alveolar macrophages serve as one of the lung’s first lines of 
defense. Alveolar macrophages must respond to invasive challenge in a way that eliminates 
challenges quickly and efficiently, while limiting inflammatory damage to the sensitive structure 
of the lung in order to maintain proper gas exchange in the tissue. Signals that override the 
homeostatic anti-inflammatory signals are required to initiate a pro-inflammatory response. Once 
an alveolar macrophage receives a large enough danger signal through PRR stimulation, alveolar 
macrophages rapidly lose contact with the alveolar epithelium, removing the brakes from a pro-
inflammatory response. Loss of contact with AECs shuts down active TGF-β signaling and induces 
fluxes in Ca2+ signaling29. Crosstalk between recruited lymphocytes and alveolar macrophages 
results in resolution of inflammation through restoration of contact of alveolar macrophages with 
the alveolar epithelium as well as active TGF-β production (Figure 2). Thus, alveolar macrophages 
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play an essential role in limiting tissue damage by maintaining and restoring proper structure of 
the lung.  
 
Figure 2. TGFb dependent contact of alveolar macrophages with alveolar epithelium. 
Contact of alveolar macrophages with the alveolar epithelium plays an important role in response to 
challenge. Figure reproduced with permission from Immunity34, copyright Elsevier Inc. 
1.2.2 Lung specific stimuli drive alveolar macrophage gene expression and homeostasis 
Alveolar macrophages are well known to be shaped by factors present in the lung 
environment. The best described lung specific signal essential for alveolar macrophage phenotype 
is GM-CSF. The alveolar epithelium is a major source of GM-CSF, which signals primarily 
through the STAT5 pathway35, 36. GM-CSF is been shown to be required for the differentiation of 
alveolar macrophages by driving expression of the transcription factor specific for alveolar 
macrophages, PPAR-γ, together with transcription factor PU.123. Alveolar macrophages that fail 
to get a proper GM-CSF signal remain stuck in a pre-alveolar macrophage state, failing to 
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upregulate CD11c, proliferate properly, and remaining functionally deficient compared to fully 
matured alveolar macrophages. 
Another tissue specific regulator of alveolar macrophage function is TGF-β. TGF-β is not 
only a potent anti-inflammatory signal maintained through communication between alveolar 
macrophages and the alveolar epithelium, but also critical for proper alveolar macrophage 
development. Similar to GM-CSF, TGF-β signal in the lung results in upregulates PPAR-γ, a 
transcription factor that is critical for alveolar macrophages. Alveolar macrophages that fail to 
receive a TGF-β signal exhibit reduced expression of PPAR-γ and remain stuck in an 
underdeveloped state, much like alveolar macrophages that fail to receive a proper GM-CSF 
signal37.  
GM-CSF and TGF-β are tissue specific factors that are critical for the unique phenotype of 
alveolar macrophages, but other lung specific factors are also likely involved. Culture of alveolar 
macrophage ex vivo results in “deprogramming” in which gene expression and regulatory signaling 
thresholds are altered due to loss of lung specific stimuli. Simply culturing “deprogrammed” 
macrophages in the presence of known tissue specific factors, such as tissue derived omentum,  is 
not sufficient to retain a “programmed” macrophage signature14.  
Further, differentiated tissue resident macrophages can be “reprogrammed” simply by 
relocation to a different tissue context16. Specifically, peritoneal macrophages transferred into the 
alveolar cavity for 15 days upregulated alveolar macrophage-specific genes, including the critical 
alveolar macrophage transcription factor, Pparg, while downregulating peritoneal macrophage-
specific genes, such as Gata6. In fact, approximately 70% of the highly differentially expressed 
genes in these transferred macrophages switched from a peritoneal macrophage expression 
signature to an alveolar macrophage expression signature. While transferred peritoneal 
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macrophages retained ~30% of their original tissue signature and failed to downregulate CD11b, 
PCA analysis confirmed these transferred macrophages more closely resembled alveolar 
macrophages than peritoneal macrophages, highlighting both the phenotypic plasticity of 
macrophages and the importance of tissue specific microenvironment in tuning specific 
macrophage signatures.  
1.2.3 Lung surfactant homeostasis and pulmonary alveolar proteinosis 
Alveolar macrophages are vital for surfactant homeostasis in the lung. Pulmonary 
surfactant is a mixture of phospholipids surfactant protein A, B, C, and D (SP-A, SP-B, SP-C, and 
SP-D) secreted by primarily by AECs38. Surfactant coats the alveoli, facilitating proper gas 
exchange by reducing surface tension and liquid interface to allow the lung tissue to expand and 
contract easily with breathing. Surfactant also plays a role in host defense through opsonization of 
microbes and particulate, as well as modulation of pulmonary immune cell function, causing 
upregulation of PRRs and regulating cytokine secretion39 40, 41. Further, surfactant has been shown 
to possess direct microbicidal activity against bacteria and fungi42. In healthy individuals, alveolar 
macrophages maintain proper surfactant levels through lipid catabolism. In cases where alveolar 
macrophage surfactant catabolism is dysregulated, individuals develop pulmonary alveolar 
proteinosis (PAP), in which surfactant builds up in the lung, causing difficulty breathing and 
pulmonary failure if left untreated43, 44. Alveolar macrophages mediate surfactant homeostasis in 
the lung and drive disease in a dysregulated state. 
Considering that GM-CSF is a critical lung-specific regulator of alveolar macrophage 
development and function, it is not surprising that alveolar macrophage-mediated surfactant 
homeostasis is dependent on GM-CSF43. Loss of GM-CSF results in dysregulated surfactant 
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maintenance and development of primary PAP. Although PAP is a disease of heterogenous origins, 
over 90% of clinical cases of primary PAP result due to disruption of GM-CSF signaling in the 
lung45. This disruption of GM-CSF signal is typically due to either autoimmune antibodies that 
neutralize GM-CSF or genetic mutations that impair the GM-CSF receptor. Disruption of the GM-
CSF signal results in dysregulation of surfactant metabolism in alveolar macrophages43. Alveolar 
macrophages develop a “foamy” phenotype in which deposits of surfactant accumulate 
intracellularly but fail to be properly catabolized (Figure 3). As PAP progresses, surfactant 
accumulates in the alveoli, continuing to be produced at the same levels by AECs, but failing to 
be properly cleared by alveolar macrophages44.  
 
 
Figure 3. GM-CSF signaling in alveolar macrophages mediates surfactant clearance. 
In a healthy lung, surfactant is taken up and degraded by alveolar macrophages, mediated by a GM-CSF 
signal. Loss of this GM-CSF signal results in reduced surfactant degradation by alveolar macrophages, and 
thus intracellular and extracellular accumulation of surfactant. Figure reproduced with permission from 
Annual Reviews of Physiology43, copyright Annual Reviews.  
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The discovery that GM-CSF deficient mice accurately recapitulate PAP pathology was a 
breakthrough that facilitated today’s understanding and treatment of PAP. Mice with deletions in 
either GM-CSF or the GM-CSF receptor both develop PAP, in which alveolar macrophages are 
severely impaired in their ability to mature and the few that do exhibit reduced functionality and a 
foamy phenotype46, 47. These GM-CSF deficient mice exhibit higher susceptibility to pulmonary 
infections as well as increased mortality from pulmonary infections, highlighting the importance 
of alveolar macrophage surfactant homeostasis in host defense48, 49. Simple replacement of GM-
CSF in GM-CSF deficient mice restores alveolar macrophage phenotype and function, surfactant 
homeostasis, and susceptibility to infection50. Therefore, GM-CSF is the major clinical target in 
PAP patients, with many primary PAP therapies involving restoration of proper GM-CSF signaling 
in the lung.  
GM-CSF serves as a prime example of a tissue specific factor exerting a critical on 
macrophage phenotype and function. Further, loss of this tissue specific factor results in impaired 
alveolar macrophage function, resulting in tissue dysregulation, and progressive pathology. Taken 
together, surfactant homeostasis mediated through alveolar macrophages via tissue-specific GM-
CSF emphasizes the importance of understanding how macrophages communicate with their tissue 
of residence in order to maintain tissue homeostasis, host protection, and overall health.  
1.2.4 Cish in regulation of signaling in alveolar macrophages 
Cytokine Inducible SH2 Containing Protein (CISH), the first described member of the 
Suppressor of Cytokine Signaling (SOCS) protein family, is induced by GM-CSF and other JAK-
STAT5 pathway activating cytokines51, 52, 53, 54. CISH binds to the phosphorylated tyrosine residues 
on cytokine receptors through its SH-2 domain, blocking sites for STAT5 to dock, and thus 
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inhibiting downstream cytokine signaling. In T cells, CISH also directly interacts with a principle 
TCR signaling component, PLCγ, targeting it for proteasomal degradation thus negatively 
regulating TCR signaling55, 56. PLCγ is directly involved in regulation of calcium flux after TCR 
stimulation, suggesting a potential role of Cish in calcium signaling. 
Although the exact molecular mechanisms of regulatory properties of Cish are unclear, 
Cish is directly implicated as important for immune responses in cancer and infections. Analysis 
of Cish polymorphisms revealed that specific variants of Cish are associated with increased 
susceptibility to infections such as malaria, tuberculosis, and bacteremia57.  Further, one specific 
SNP CISH variant is significantly associated with susceptibility to hepatitis B virus infection58. 
Although Cish is best described in T cells, emerging research shows Cish is an important regulator 
of immune responses in macrophages. Two recent publications show that Cish mediates immune 
response in bone marrow derived macrophages (BMDM) in M. tuberculosis infection in vitro. 
Studies found dysregulation of cytokine secretion and decreased bacterial burden in Cish-/- 
BMDM infected with M. tuberculosis, compared to WT BMDM. Macrophage expression of CISH 
was induced by STAT5 activation through the GM-CSF signaling in response to M. tuberculosis 
infection. Cish was shown to directly regulate endosome acidification, identifying a novel role of 
Cish in regulation of immune response59. Considering the previously unappreciated function of 
Cish in macrophages and its regulation by GM-CSF, additional research is needed to elucidate the 
tissue-specific function of Cish in alveolar macrophages. 
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2.0 Statement of the Project 
In this project, we seek to investigate tissue specific signals that drive specialized functions 
in tissue resident macrophages. Specifically, we will examine the influence of cytokines present 
in the lung microenvironment on alveolar macrophage gene expression and function. We will test 
the hypothesis that lung specific cytokines induce lung specific signaling genes that regulate 
specialized functions in alveolar macrophages. 
2.1 Aim 1: Investigate Tissue Specific Regulation of Cish in Alveolar Macrophages 
Tissue resident macrophages have distinct gene expression signatures corresponding to 
tissue specific functions. We describe high basal Cish expression specifically in alveolar 
macrophages, compared to other macrophage subsets, and elucidate lung specific factors that 
regulate alveolar macrophage Cish expression. 
2.2 Aim 2: Investigate Tissue Specific Function of Cish in Alveolar Macrophages 
Considering the high level of Cish expression in alveolar macrophages, we hypothesize 
that Cish plays role in lung homeostasis. We utilize a Cish deficient mouse model to examine Cish-
dependent changes in alveolar macrophage phenotype and function, and in overall lung 
homeostasis. 
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3.0 Materials and Methods 
3.1 Mice 
Wild type and Cish knockout mice, generously provided by Dr. Nicholas Restifo56,  were 
all from a wild-type C57BL/6J background (Jackson Laboratories). Mice were maintained in 
specific-pathogen-free conditions and all procedures were approved by the Institutional Animal 
Care Committee of the University of Pittsburgh (IACUC). 
3.2 Cells 
3.2.1 Mouse bone marrow derived macrophages (BMDM) 
Bone marrow progenitors isolated from mice were differentiated into BMDM during a 6 
day culture in complete Dulbecco’s modified Eagle’s medium (DMEM + 10% FBS, 100 U/ml 
penicillin, 100 U/ml streptomycin, 2 mM L-Glutamine, 20 mM HEPES) supplemented with 60 
ng/ml recombinant mouse M-CSF (R & D systems). One day prior to stimulation, cells were rinsed 
with cold PBS, then scraped from plates using a cell lifter. Cells were then plated in the appropriate 
tissue-culture-treated plate in complete DMEM and allowed to rest overnight at 37°C, 5% CO2, 
95% relative humidity prior to stimulation. 
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3.2.2 BMDM stimulation 
BMDM were plated at 1 x 104 cells/well on 96-well black imaging plates (Greiner Bio-
One) for immunofluorescent phagocytosis assays and 2 x 105 cells/well on 48-well plates (Greiner 
Bio-One) for GM-CSF stimulation. For immunofluorescent phagocytosis assays, BMDM were 
stimulated with (concentration) fluorescent S. aureus bioparticles (Invitrogen). Following 
stimulation, cells were fixed and stained for immunofluorescent imaging analysis. For GM-CSF 
stimulation, BMDM were stimulated with 20 ng/mL of GM-CSF (Biolegend). Following 
stimulation, cells were lysed in TRIzol Reagent (Ambion) and RNA was isolated for gene 
expression analysis.  
3.2.3 Alveolar macrophage harvest and sorting 
Lungs were harvested into gentleMACS C tubes (Miltenyi Biotec) containing lung 
digestion buffer (1X PBS, 0.5% FBS, 10µg/mL Liberase TM, and 10U/mL DNase I). Lungs were 
minced to 1mm3 size pieces and moved to a shaker for 30 minutes at 37° C. Lungs were then 
further dissociated using program “m_lung_02_01” on the gentleMACS Dissociator (Miltenyi 
Biotec). Lung cell homogenates were filtered through a 70 µm filter and red blood cells were lysed 
with ACK Lysing Buffer (Lonza). Cells were stained with CD11c-BV421 (Biolegend) and  Siglec-
F-PE (BD Biosciences). CD11c+, Siglec-F+ cells were sorted directly into TRIzol Reagent 
(Ambion) using the BD FACSAria II (BD Biosciences).  
 16 
3.2.4 BAL alveolar macrophage stimulation 
Alveolar macrophages were harvested by bronchoalveolar lavage (BAL). Red blood cells 
were lysed using ACK Lysing Buffer (Lonza) and cells were resuspended in complete DMEM and 
plated at approximately 1 x 104 cells per well (200 µL/well) in a 96 well plate. After resting cells 
for 30 minutes, cells were stimulated with 20 ng/mL of recombinant mouse GM-CSF (Biolegend).  
3.3 Broncholaveolar Lavage 
3.3.1 Bronchoalveolar lavage harvest 
Lungs were lavaged with 1 mL phosphate buffered saline (PBS) containing 5% FBS 
(Corning) and 100uM EDTA (Teknova). BAL cells were then spun down, supernatant was saved, 
and BAL cells were used for further experimentation.  
3.3.2 SP-D ELISA 
BAL supernatant SP-D concentration was assessed using the Mouse SP-D ELISA Kit 
(Abcam), according to manufacturer’s directions. Plates were read using the Epoch Microplate 
Spectrophotometer (BioTek Instruments). 
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3.4 Gene Expression 
3.4.1 qPCR 
Samples were lysed in TRIzol Reagent (Ambion). RNA was isolated used Directzol RNA 
MicroPrep kit (Zymo Research), according to manufacturer’s directions. RNA was quantified 
using a Nanodrop. RNA was reverse transcribed to using cDNA was generated using qScript 
cDNA SuperaMix (Quantabio). qPCR was performed using TaqMan probes (Thermo Scientific) 
on the CFX96 Real-Time System (BioRad). Analyses were performed using the ∆∆Ct method 
comparing genes of interest to a Gapdh control. 
3.4.2 RNAseq 
Alignment and raw read counts were generated using Rsubread and then normalized using 
DESeq2. DESeq2 was then used to calculate the log fold changes between sample groups. Low 
expression genes were removed along with genes that were not differentially expressed (adjusted 
p-value ≤ 0.05) in at least one group. Remaining DESeq2 normalized reads were then z-score 
normalized. Genes were then hierarchically clustered, using complete linkage and correlation as a 
distance metric. Pathway specific heat maps were generated using gene sets from PathCards 
(Weizmann Institute of Science).  
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3.5 Imaging 
3.5.1 Immunofluorescent staining and imaging 
After stimulation, cells were fixed with 4% PFA for 10-15 minutes. Cells were then 
blocked with Blocking Buffer (1X PBS with 5%goat serum, 0.3% TritonTM X-100). After 
blocking, cells were stained with primary antibody diluted in antibody dilution buffer (1X PBS, 
1% BSA, 0.3% Triton X-100) overnight at 4° C. BMDM were stained with the primary antibodies 
CD11b, followed by secondary antibodies: alveolar macrophages were stained with the following 
primary antibodies: hamster anti-mouse CD11c (1:200, Biolegend) and rabbit anti-mouse pSTAT5 
(1:200, Cell Signaling Technology), followed by secondary antibodies: anti-hamster Cy3 (1:500, 
Jackson ImmunoResearch) and anti-rabbit AlexFluor 488 (1:500, Invitrogen). All cells were 
stained with Hoescht 3342 (ThermoFisher Scientific). After staining cells were washed extensively 
with PBS and imaged using the Cellnsight CX5 High Content Screening Platform (ThermoFisher 
Scientific).  
3.5.2 Oil Red O staining and imaging 
BAL alveolar macrophages were plated on a 96 well black imaging plate and fixed with 
10% Formalin for 1 hour. After fixation cells were washed with 60% isopropanol and allowed to 
dry completely. Cells were then stained with Oil Red O for 10 minutes and washed extensively 
with H2O. Images were acquired using the IX83 Inverted Microscope (Olympus).  
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3.6 Western Blot Analysis 
Lung tissue was lysed on ice (10 mM TrisHCl, 140 mM NaCl, 2 nM EDTA, 1% NP40 
lysis buffer containing Roche PhosSTOP and cOmplete ULTRA phosphatase and protease 
inhibitors). Protein concentration was determined using Pierce BCA Protein Assay Kit 
(ThermoFisher Scientific). Samples were diluted using 4X Laemeli Sample buffer and heated to 
99°C for 10 minutes. Equal amounts of protein were then loaded into a pre-cast 4-20% TGX gel 
(BioRad). Protein was transferred to a nitrocellulose membrane (BioRad) and then blocked in 5% 
milk for 1 hour and probed with p-STAT3 (1:1000, Cell Signaling Technology), p-STAT5 
(1:1000, Cell Signaling Technology), followed by anti-rabbit HRP-conjugated secondary antibody 
(1:3000, Cell Signaling Technology). Blots were developed with FluorChem M (ProteinSimple). 
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4.0 Results 
4.1 Aim 1: Investigate Tissue Specific Regulation of Cish in Alveolar Macrophages 
4.1.1 Cish expression is tissue specific 
Using the Immgen RNAseq Gene Skyline to compare Cish expression across various tissue 
resident macrophages, we found high Cish expression is unique to alveolar macrophages (Figure 
1A). We next sought to determine if Cish expression in alveolar macrophages is dependent on 
factors present in the lung. We analyzed Cish expression in alveolar macrophages freshly 
harvested versus cultured ex vivo in media and found dramatic reduction of Cish in alveolar 
macrophages after removal from the lung (Figure 1B). This is consistent with the hypothesis that 
alveolar macrophage Cish expression is dependent on factors present in the lung environment. We 
also investigated tissue specific expression of Cish using publish RNAseq data16. Peritoneal 
macrophages transferred into the lung for 15 days increased expression of Cish to expression levels 
comparable to alveolar macrophages (Figure 1C), further suggesting Cish expression is dependent 
on lung specific factors. 
 21 
 
Figure 4. Cish expression in macrophages is lung specific. 
(A) Expression of Cish across subsets of tissue resident macrophages (Immgen). (B) Cish expression in 
BAL macrophage either fresh from the lung, or cultured in media for 2 or 48 hours quantified by pPCR. 
(C) Expression of Cish in alveolar macrophages, peritoneal macrophages, or peritoneal macrophages 
transferred into the lung after 15 days.   
 
4.1.2 GM-CSF regulates Cish expression 
Cish is well described to regulate and be regulted by STAT553, 54, leading us to investigate 
STAT5 inducing cytokines present in the lung. GM-CSF not only signals through the STAT5 
pathway36, but is also highly expressed in the lung and known to shape alveolar macrophage 
development and phenotype23. We first tested the ability of GM-CSF to induce Cish expression in 
bone marrow derived macrophages (BMDM) and found GM-CSF stimulation resulted in strong 
induction of Cish (Figure 5A).  
To better understand the relationship between GM-CSF and Cish expression in vivo, we 
compared whole lung Csf2 expression to alveolar macrophage Cish expression across individual 
WT mice, and found a significant correlation (R2= 0.828, p=0.0017) between the two (Figure 5B). 
This suggested to us that GM-CSF in the lung plays a role in alveolar macrophage Cish expression 
in vivo. We next tested the effect of blocking GM-CSF in the lung by administering either anti-
 22 
GM-CSF or isotype control antibodies intranasally over the course of three days. We found that 
GM-CSF blockade in the lung resulted in significant (p=0.0327) reduction of Cish expression in 
alveolar macrophages (Figure 5B). To assess the efficacy of our blockade, we also measured 
expression of Mrc1 and Pparg, both described to be regulated GM-CSF in alveolar macrophages23, 
60. We found a modest, bu significant reduction of Mrc1, but non-significant reduction of Pparg, 
suggesting only partial GM-CSF blockade in the lung (Figures 5D & 5E).  
 
Figure 5. GM-CSF regulates Cish expression. 
(A) Cish expression in BMDM after stimulation with GM-CSF (20 ng/mL) quantified by qPCR. (B) Whole 
lung Csf2 expression versus BAL alveolar macrophage Cish expression in WT BL6 mice quantified by 
qPCR. Expression of (C) Cish, (D) Mrc1, and (E) Pparg  in alveolar macrophages (CD11c+, Siglec-F+) 
sorted from WT BL6 mice after three day intranasal administration of anti-GM-CSF (red) or isotype control 
(black) antibodies.  
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4.2 Aim 2: Investigate Tissue Specific Function of Cish in Alveolar Macrophages 
4.2.1 Dysregultion of lung homeostasis in Cish KO mice 
A previous study reported that Cish KO mice develop spontaneous lung disease, noting 
consolidation of airways due to deposit of proteinaceous material and mononuclear infiltrates, with 
disease worsening with age61. This study focused on the role of Cish in T cells using a model of 
induced lung inflammation, failing to further characterize the spontaneous disease or to assess 
potential contribution of alveolar macrophages, which express high levels of Cish. Therefore, we 
sought to investigate Cish KO lung disease, with specific focus on Cish in alveolar macrophages. 
We compared lung samples from 4 month old (young) and 12 month old (old) Cish KO mice to 
age matched WT controls. To assess cytokine signaling on the protein level, we examined whole 
lung lysates by Western blot and we found increased STAT3 and STAT5 activation in Cish KO 
mice compared to WT controls (Figure 6A). This suggested dysregulation of cytokine signaling in 
lungs of Cish KO mice. To better assess cytokine regulation at a gene expression level, we assessed 
whole lungs by qPCR analysis. We found a trend of increased expression of proinflammatory 
chemokines and cytokines, Cxcl1, Ccl2, Ccl3, Il6, and Csf2 in the lungs of old Cish KO mice 
(Figure 6B-F). In addition, we observed a trend of decreased expression of Stat5a in the lungs of 
Cish KO mice compared to WT mice in both the young and the old groups (Figure 6G), further 
evidence suggesting dysregulation of the STAT5 network Cish KO lungs.  
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Figure 6. Cish KO mice exhibit cytokine dysregulation in the whole lung. 
(A) Western blot analysis of the whole lung in young (4 month) and old (1 year) WT and Cish KO mice. 
RhoGDI was used as a loading control. (B-G) qPCR analysis of the whole lung in young (4 month) and old 
(1 year) WT and Cish KO mice. 
 
Based on our finding that GM-CSF regulates Cish expression in alveolar macrophages 
(Figure 5) and observation of whole lung dysregulation of GM-CSF/STAT5 signaling in Cish KO 
mice exacerbated by age (Figure 6), we sought to further investigate Cish in the context of GM-
CSF/STAT5 related alveolar macrophage dysfunction. Aberrant GM-CSF signaling in alveolar 
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macrophages results in pulmonary alveolar proteinosis (PAP), in which alveolar macrophages fail 
to adequately degrade surfactant in the absence of a proper GM-CSF signal43, 44, 47, 50. When we 
assessed levels of surfactant in the BAL, we found elevated levels of surfactant protein D (SP-D) 
in the Cish KO mice (Figure 7A). Further, we noticed increased granularity (SSC-A) in alveolar 
macrophages from old Cish KO mice, as well as a trend of increased size (FSC-A) in alveolar 
macrophages from the old and young Cish KO mice, compared to WT controls (Figure 7B), 
consistent with the foamy alveolar macrophage phenotype seen with dysregulation of surfactant 
homeostasis62.  
To better assess whether this increased size and granularity was due to intracellular 
accumulation of surfactant in alveolar macrophages, we performed an Oil Red O stain, which 
stains neutral lipids. BAL macrophages from Cish KO mice exhibited notably increased staining 
with Oil Red O compared to WT controls (Figure 7C), further suggestive of a foamy alveolar 
macrophage phenotype, consistent with PAP63, 64. We then looked specifically at expression of 
gene related to surfactant metabolism (PathCards, Weizmann Institute of Science) in alveolar 
macrophages sorted from young and old Cish KO and WT mice. We noted dysregulation of 
surfactant metabolism gene expression in the Cish KO alveolar macrophages, compared to WT 
mice, exacerbated with age (Figure 7D). Taken together, these results are highly suggestive of a 
PAP like pathology developing in Cish KO mice. Cish KO mice exhibit the hallmarks of PAP, in 
which improper surfactant homeostasis results in accumulation of surfactant in the BAL and foamy 
alveolar macrophages with increase in size and granularity due to improper intracellular surfactant 
metabolism43, 44, 47, 50, 63, 64, 65. 
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Figure 7. Cish KO mice develop PAP-like phenotype. 
(A) Levels of SP-D in BAL supernatant from 4 month old mice quantified by ELISA, with individual 
experiments internally normalized to WT controls. An age matched Cs2f-/- mouse was included as a PAP 
control (B) Mean SSC-A (top panel) and mean FSC-A (bottom panel) in alveolar macrophages flow sorted 
on Siglec-F+, CD11c+ cells from lungs of young (4 month) and old (1 year) Cish KO and WT mice. (C) 
Representative Oil Red O stain from 4 month old Cish KO and WT mice. (D) RNAseq heat map for 
surfactant metabolism from sorted alveolar macrophages (same as B).  
 
4.2.2 Cell intrinsic implications of Cish deficiency in alveolar macrophages 
We sought to explore the mechanism by which this PAP-like phenotype develops in Cish 
KO mice. Due to numerous studies reporting that PAP is driven by loss of a proper GM-CSF signal 
to alveolar macrophages43, 47, 50, we investigated the response of Cish KO alveolar macrophages to 
GM-CSF stimulation. We harvested alveolar macrophages from Cish KO and WT mice by BAL, 
stimulated them ex vivo with GM-CSF, and quantified pSTAT5 by immunofluorescence. We first 
noted that unstimulated Cish KO alveolar macrophages displayed significantly reduced average 
pSTAT5 intensity compared to WT (Figure 8A), consistent with dysregulated STAT5 signaling in 
vivo. When stimulated with GM-CSF, we noticed that average pSTAT5 signal remained markedly 
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reduced in Cish KO alveolar macrophages compared to WT alveolar macrophages (Figure 8B). 
However, when plotted as a fold change, we noticed that the average pSTAT5 signal appeared 
more sustained at later timepoints in Cish KO alveolar macrophages compared to WT alveolar 
macrophages (Figure 8C). Though preliminary, these data suggest a failure to properly turn off the 
STAT5 signal, consistent with loss of Cish, a negative regulator of STAT5 signaling.  
To gain insight into the impact of Cish deficiency in regulation of GM-CSF signaling in 
alveolar macrophages in vivo, we plotted a gene expression for a GM-CSF signaling gene set 
(PathCards, Weizmann Institute of Science) across sorted young and old Cish KO and WT alveolar 
macrophages (Figure 8E). In this heat map, we noticed distinct gene expression patterns across 
Cish KO and WT alveolar macrophages, with the most robust differences in the old Cish KO 
alveolar macrophages. This is consistent with aberrant GM-CSF mediated STAT5 signaling in 
Cish KO alveolar macrophages.  
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Figure 8. Cish KO alveolar macrophages exhibit dysregulated response to GM-CSF. 
Immunofluorescent imaging analysis of Cish KO and WT alveolar macrophages from 4 month old 
mice with (A) quantified pSTAT5 average intensity unstimulated and ex vivo GM-CSF (20 ng/mL) 
stimulation over time quantified by (B) average pSTAT5 intensity and (C) pSTAT5 average 
intensity fold change. (D) Representative immunofluorescent images. (E) RNAseq heatmap of 
GM-CSF signaling pathway of sorted alveolar macrophages (CD11c+, Siglec-F+) sorted from 
young (4 month) and old (1 year) Cish KO and WT mice. 
 
We next sought to further explore cell intrinsic functions of Cish in relation to macrophage 
function. Considering that Cish KO alveolar macrophages already exhibited impaired clearance of 
surfactant, we decided to test if Cish plays a role in phagocytosis of microbes, a critical function 
of all macrophages, especially at barrier sites such as the lung. We first quantified Cish KO and 
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WT BMDM internalization of fluorescent S. aureus bioparticles via immunofluorescent imaging. 
We found that Cish KO BMDM exhibited impaired phagocytosis of S. aureus bioparticles at later 
timepoints compared to WT BMDM (Figure 9A). This must be tested in alveolar macrophages to 
draw meaningful conclusions about Cish function in the context of the macrophages in the lung.  
Although Cish is best described as a regulator of JAK/STAT5 signaling, Cish has also been 
described to regulate calcium signaling in T cells55. Phagocytosis in macrophages is mediated by 
a calcium signal66, 67, 68, 69, and thus dysregulated phagocytosis in Cish KO BMDM could be related 
to improper regulation of calcium signaling. We speculated that Cish KO alveolar macrophages 
could also have dysregulated calcium signaling, in addition to impaired STAT5 regulation. When 
we plotted calcium signaling gene expression across alveolar macrophages sorted from young and 
old Cish KO and WT mice, we indeed found different gene expression patterns in Cish KO alveolar 
macrophages compared to WT macrophages, with the most robust difference appearing the old 
Cish KO alveolar macrophages (Figure 9C). This is consistent with our hypothesis that Cish plays 
a role in alveolar macrophage calcium signaling, but requires further investigation.  
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Figure 9. Cish KO macrophages exhibit potential calcium dysregulation. 
(A) Immunofluorescent imaging analysis of Cish KO and WT BMDM (CD11b+ cells, green) phagocytosis 
of fluorescent S. aureus bioparticles (light blue) quantified by mean fluorescent intensity of S. aureus 
bioparticles within BMDM. (B) Representative images of immunofluorescent phagocytosis assay at the 5 
hour time point. (C) RNAseq heatmap of calcium signaling pathway of sorted alveolar macrophages 
(CD11c+, Siglec-F+) sorted from young (4 month) and old (1 year) Cish KO and WT mice. 
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5.0 Discussion 
Macrophages reside in nearly every organ of the body, where they perform a variety of 
functions that extend beyond simple immune surveillance of their host. These various functions 
typically coincide with their tissue of residence, where they crosstalk with other cells present in 
the tissue to maintain overall tissue homeostasis. For example, microglia work to remodel neurons, 
by eliminating dead neurons and stimulating growth of new ones8, 24. Bone marrow macrophages 
play a pivotal role in generation of new red blood cells6 and red pulp macrophages remove old red 
blood cells from circulation21. Increasingly, tissue resident macrophages are being appreciated for 
their communication with their tissue of residence and their role in tissue homeostasis.  
In addition to possessing distinct roles across different tissues, tissue resident macrophages 
have also been shown to have distinct gene expression patterns16, 17, 18. Many speculate that tissue 
specific factors are responsible for these driving distinct gene expression signatures, and in turn 
phenotypes and tissue specific functions. While there is emerging evidence to support this idea, 
the tissue specific signals responsible for informing these unique signatures remain poorly defined. 
In addition, the link between tissue specific gene expression and tissue specific function remains 
relatively vague, with few concrete examples. Therefore, in this project we sought to uncover lung 
specific drivers of alveolar macrophage gene expression and in turn lung specific function, with 
specific emphasis on cytokine signals present in the steady state lung microenvironment. 
We indeed found that expression of Cish, a SOCS regulator of STAT5 signaling53, is 
specific to alveolar macrophages and is dependent on factors present in the homeostatic lung 
microenvironment (Figure 4). Further, we found that regulation of Cish in alveolar macrophages 
is dependent on GM-CSF (Figure 5), which is well described to signal through the STAT5 pathway 
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and highly expressed in the steady state lung environment35, 36. However, while GM-CSF blockade 
in the lung was sufficient to significantly decrease Cish expression in alveolar macrophages, we 
speculate there are likely additional signals present within the lung microenvironment that drive 
expression of Cish in alveolar macrophages. 
In addition to addressing the regulation of this alveolar macrophage specific gene, Cish, 
we also sought to investigate the function of Cish in alveolar macrophages by studying the effect 
of Cish deficiency in a mouse model. Based on previous reports of Cish KO mice developing 
spontaneous pulmonary disease with age61, we posited that Cish deficiency results in dysregulated 
lung homeostasis which worsens with age and is mediated by alveolar macrophages, an abundant 
immune cell in the lung expressing high levels of Cish. Therefore, we aged Cish KO mice and WT 
controls to better define the pulmonary disease and specifically examine the contribution of Cish 
deficiency within alveolar macrophages to disease development. We recapitulated the previous 
finding of Cish KO mice developing lung disease which worsened with age. Elaborating on this 
study, we found that this lung disease closely resembled pulmonary alveolar proteinosis, with 
alveolar macrophages as major drivers of this disease phenotype.  
Because our primary focus was on steady state cytokine signals in the lung, we first 
examined the impact of loss of a tissue specific cytokine regulator, Cish, on lung cytokine 
homeostasis. As mice aged, we found that Cish KO mice exhibited dysregulated cytokine balance 
in the whole lung, specifically with increased activation of STAT3 and STAT5, as well as trends 
towards increased production of pro-inflammatory chemokines and cytokines. We also noticed 
trends towards increased Csf2 expression and decreased Stat5a expression in the lungs of Cish KO 
mice (Figure 6). Taken together, these results pointed to aberrant GM-CSF/STAT5 signaling in 
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the lung in Cish KO, which was not surprising considering previous reports describing Cish as a 
STAT5 regulator36.  
We sought to more closely examine the implications of this aberrant GM-CSF/STAT5 
signaling on overall lung homeostasis mediated by alveolar macrophages. Literature review 
revealed that GM-CSF signaling is not only critical for alveolar macrophage development23, but 
also for alveolar macrophage mediated pulmonary surfactant homeostasis43. In people, loss of a 
GM-CSF signal to alveolar macrophages in the lung, most typically through autoimmune 
antibodies against GM-CSF, results in pulmonary alveolar proteinosis, in which alveolar 
macrophages fail to properly degrade surfactant, leading to accumulation of surfactant in the 
lung45. Due to our initial finding of improper GM-CSF/STAT5 signaling in the whole lung in Cish 
KO mice in addition to the previous finding of Cish KO developing spontaneous lung disease in 
which filling of the alveoli with proteinaceous material was observed, we sought to examine the 
possibility that Cish KO mice develop PAP, mediated by improper GM-CSF/STAT5 signaling in 
alveolar macrophages.  
When we examined the broncheoavleolar lavage fluid we noticed elevated levels of 
surfactant protein in Cish KO mice. Additionally, we noted “foamy” alveolar macrophages in Cish 
KO mice, with increased size and granularity, consistent with the phenotypic hallmark of PAP, as 
alveolar macrophages in PAP increase in size and granularity as surfactant accumulates 
intracellularly, failing to be properly metabolized62. We stained for intracellular lipid 
accumulation, and also saw increased intracellular lipid deposition in Cish KO alveolar 
macrophages, another hallmark of PAP63, 64. Further, when we looked at a gene set for surfactant 
metabolism, we noticed differences in gene expression in Cish KO alveolar macrophages 
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compared to WT macrophages, supporting the notion that alveolar macrophages Cish deficiency 
results in improper pulmonary surfactant homeostasis (Figure 7).  
To further address the cell intrinsic mechanisms by which Cish deficiency results in 
dysregulated alveolar macrophage mediated surfactant homeostasis, we tested alveolar 
macrophage GM-CSF mediated STAT5 signaling ex vivo. Although preliminary results, we 
noticed that alveolar macrophages from Cish KO mice contained lower basal levels of pSTAT5 
compared to WT alveolar macrophages, suggesting lack of responsiveness to GM-CSF in Cish 
KO alveolar macrophages. When stimulated with GM-CSF ex vivo, Cish KO alveolar 
macrophages activated STAT5 at levels consistently less than WT alveolar macrophages. In 
addition, pSTAT5 signaling remained at more sustained levels at later timepoints in Cish KO 
alveolar macrophages compared to WT alveolar macrophages, consistent with loss of a negative 
regulator of STAT5 signaling (Figure 8). Additional experimentation is required to further explore 
these differences. 
We next sought to explore immune implications of Cish deficiency in macrophages, 
specifically in relation to response of microbes. We tested the ability of Cish KO macrophages to 
phagocytose microbes, as alveolar macrophages from other PAP models have been reported to 
exhibit defects in phagocytosis47, 65. Although our results are preliminary and only tested so far in 
BMDM, we noticed significant impairment of phagocytosis of S. aureus bioparticles in Cish KO 
BMDM (Figure 9A). We suspect that this impaired phagocytosis is due to improper regulation of 
a calcium signal mediated by Cish, as Cish has been implicated in regulation of calcium 
signaling55. Although this requires further examination in alveolar macrophages, this inspired us 
to look specifically at expression of genes in calcium signaling pathways in our sorted alveolar 
macrophage RNAseq dataset. We found that Cish KO alveolar macrophages exhibited notably 
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different gene expression patterns compared to WT alveolar macrophages, especially in the old 
Cish KO alveolar macrophages (Figure 9C), further suggesting a potential role for Cish in calcium 
signaling in alveolar macrophages, independent of STAT5 signaling. 
In this study, we show that Cish is expressed in a lung specific manner in alveolar 
macrophages and that Cish expression is regulated by GM-CSF present in the lung. Further, Cish 
expression in alveolar macrophages is important for their homeostatic role in the lung, namely 
surfactant homeostasis. While previous studies have hinted at tissue specific regulators being 
expressed in a tissue specific manner and informing tissue specific functions of macrophages, this 
study provides concrete evidence to support this idea. 
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6.0 Future Directions 
These results highlight the tissue specific function of Cish in alveolar macrophages, in 
which Cish deficiency results in apparent dysregulation of lung homeostasis, namely through 
improper cytokine balance and improper surfactant clearance. While we present a strong case for 
Cish deficiency leading to PAP, as evidenced foamy alveolar macrophages and increased levels of 
pulmonary surfactant in Cish deficient mice, this study could be strengthened by lung histology 
showing PAP as well. Architectural issues with initial histology prevented us from showing these 
results with confidence, but our initial histological results were supportive of development of PAP 
in Cish KO mice (data not shown). We are undergoing further optimization of lung histology in 
order to definitively address this. 
Additionally, while we show imbalance of cytokines present in the lungs of Cish KO mice, 
future studies addressing the mechanisms with which this occurs over time would provide more 
insight into how alveolar macrophage Cish expression tunes proper cytokine signaling in the lung. 
To address this, we would need to carefully examine the balance of cytokine expression and 
secretion in the lungs of Cish KO mice as they age. Better understanding the dynamics by which 
cytokines are dysregulated in the lungs of Cish KO mice would provide insight into the complex 
crosstalk of cells in the lungs as well as inform further experimentation into additional implications 
of improper cytokine homeostasis in the lung.  
While we are beginning to further explore cell intrinsic effects of Cish deficiency in 
alveolar macrophages, such as response to GM-CSF and calcium signaling, additional research is 
required to explore the mechanisms by which Cish regulates these cell intrinsic functions within 
alveolar macrophages. Our preliminary results suggest that Cish KO alveolar macrophages have 
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impaired responses to GM-CSF/STAT5 signaling, but the mechanism with which Cish regulates 
this signal in alveolar macrophages needs to be further addressed. Based on our initial findings, 
we speculate that Cish deficiency results in a prolonged STAT5 signal, failing to properly shut off 
due to lack of Cish.  
Based on preliminary findings, we also speculate that Cish likely plays a role in regulating 
calcium signals in alveolar macrophages. While we focused on phagocytosis in this study, calcium 
signaling is also important for a number of cellular functions, such as cell adhesion, cytokine 
production, and response to oxygen70, 71, 72. Thus improper regulation of calcium signaling could 
have a wide range of effects for alveolar macrophage mediated lung homeostasis and protection. 
We are beginning to investigate calcium signaling in response to various stimuli in Cish KO and 
WT alveolar macrophages to address whether Cish regulates calcium signals in alveolar 
macrophages. 
Further, we wish to understand the impacts of these cell intrinsic functions of Cish for 
overall lung homeostasis and protection. Based on preliminary data, we suspect that alveolar 
macrophage Cish deficiency results in worsened outcome upon bacterial challenge in the lung, 
with decreased survival and increased weight loss in Cish KO mice (data not shown). These results 
would be consistent an SNP analysis showing that specific Cish variants have increased 
susceptibility to pulmonary infections, suggesting proper regulation of immune response mediated 
by Cish plays an important role in protection of the lung57, 58. These results would also be consistent 
with other PAP models, in which alveolar macrophages in PAP have been shown to exhibit 
impaired immune responses to various microbes47, 65. 
We predict that alveolar macrophage Cish deficiency would lead to defective immune 
responses to pulmonary pathogens, namely through dysregulated cytokine responses, leading to 
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overall worsened outcome in pulmonary infections. We also speculate that calcium signaling, 
shown to be important in communication between alveolar macrophages especially in the context 
of infection, could be dysregulated in a Cish KO model. Mechanisms by which Cish regulates 
responses to microbes in alveolar macrophages and implications for outcome of lung infection 
need to be addressed experimentally. 
In addition to worsened outcome in instances of pulmonary infection, we also predict that 
Cish deficient alveolar macrophages have irregular responses to microbes present in the lung in 
the steady state. The lung has been shown to harbor its own unique microflora and alveolar 
macrophages typically detect these microbes quiescently, without generating pro-inflammatory 
responses73. We speculate that Cish KO alveolar macrophages would be either hyper or hypo-
responsive to microbes in the steady state lung environment, either causing unnecessary lung 
damage or allowing opportunistic infections respectively.  
One major shortcoming of this project is use of a global Cish KO mouse model. Although 
this model is sufficient for showing tissue specific regulation and function of Cish in alveolar 
macrophages, a handful of other immune cells including as CD8+ T cells can express Cish. To 
address this shortcoming, moving forward the ideal model to use would be a conditional Cish KO, 
likely under transcriptional control of Cx3cl1, which is uniquely highly expressed by alveolar 
macrophages. This conditional Cish KO model would be able to address whether Cish deficiency 
in other cell types in the lung further contribute to the phenotype we describe in this study, as well 
as in future experimentation. 
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7.0 Public Health Significance 
Our study specifically found a spontaneous PAP like phenotype driven by Cish deficiency, 
highlighting the importance of tissue specific regulatory signaling in maintenance of tissue 
homeostasis. This loss of proper lung homeostasis has numerous implications for the host, from 
proper protection of the lung to simple ability to breathe in severe cases of disease, a critical barrier 
site. From a public health perspective, continuing to elucidate the specific mechanisms by which 
alveolar macrophages mediate lung homeostasis is essential to providing cutting edge health care 
and to continuing to develop therapeutic treatments that can provide cures instead of simply 
mitigating symptoms of pulmonary disease. 
From a human health standpoint, SNP analysis across Cish variants found that specific 
variants of Cish are more highly susceptible to various infections, such as malaria, tuberculosis,  
bacteremia, and hepatitis B, further emphasizing the importance of signaling regulators, 
specifically Cish in this case, in host protection57, 58. Further, although PAP is a relatively rare 
disease, individuals with PAP are more susceptible to various pulmonary and systemic infections, 
such as tuberculosis45. In addition to being the major drivers of PAP, alveolar macrophages in PAP 
have also been shown to exhibit dysregulated immune responses, such as defects in expression of 
PRRs, secretion of cytokines, phagocytosis, and microbial killing47, 65.  
This study emphasizes that alveolar macrophage function has implications not only for 
overall lung structure and function, but also that impaired lung homeostasis can lead to impaired 
tissue protection. Elucidating the signals that are responsible for proper lung homeostasis is vital 
to better understand the complex crosstalk between cells in the lung and to understand how these 
signals get dysregulated in order to create better targets in treatment of various pulmonary diseases. 
 40 
Therefore, better understanding the mechanisms with which alveolar macrophage mediate lung 
homeostasis is critical for continuing to provide the best health care and treatments to individuals 
with pulmonary disease or infection. 
 41 
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